butylhydroxybutylnitrosamine has been researched along with Hormone-Dependent Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gonzalgo, ML; He, Y; Hooker, E; Johnson, DT; Luong, R; Sun, Z; Yu, EJ | 1 |
Izumi, K; Li, Y; Miyamoto, H | 1 |
1 review(s) available for butylhydroxybutylnitrosamine and Hormone-Dependent Neoplasms
Article | Year |
---|---|
The role of the androgen receptor in the development and progression of bladder cancer.
Topics: Animals; Butylhydroxybutylnitrosamine; Carcinogens; Castration; Disease Models, Animal; Disease Progression; Evidence-Based Medicine; Female; Gene Expression Regulation, Neoplastic; Humans; Incidence; Male; Neoplasms, Hormone-Dependent; Receptors, Androgen; Risk Factors; Sex Factors; Signal Transduction; Urinary Bladder Neoplasms | 2012 |
1 other study(ies) available for butylhydroxybutylnitrosamine and Hormone-Dependent Neoplasms
Article | Year |
---|---|
Conditional Expression of the Androgen Receptor Increases Susceptibility of Bladder Cancer in Mice.
Topics: Androgens; Animals; Butylhydroxybutylnitrosamine; Carcinoma, Transitional Cell; Cell Division; Cell Transformation, Neoplastic; Drug Implants; Female; Genetic Predisposition to Disease; Humans; Integrases; Male; Mice; Mice, Transgenic; Neoplasms, Hormone-Dependent; Orchiectomy; Promoter Regions, Genetic; Receptors, Androgen; Recombinant Fusion Proteins; Tamoxifen; Testosterone; Transgenes; Urinary Bladder Neoplasms; Uroplakin III | 2016 |